Global Endocrine Testing Market Projected to Reach USD 2.03 Billion by 2019: Transparency Market Research

Albany, NY, April 03, 2014 --( Transparency Market Research has added a new report titled “Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019” to its database.

In a latest market report published by Transparency Market Research, the leading U.S.-based market research firm says that the global market for Endocrine Testing, which was worth USD 1.53 billion 2012, is projected to be worth USD2.03 billion by 2019. This market is estimated to demonstrate a compounded annual growth rate of 4.3% between the forecast period of 2013 and 2019.

Browse full report with TOC:

The endocrine system is a critical system in humans that comprises a group of endocrine glands and secreting organs. These glands and organs perform the crucial function of releasing hormones into the blood stream directly.

This is what makes the proper functioning of the endocrine system so essential to multiple body mechanisms. The endocrine system regulates various body mechanisms including growth, metabolism, sexual functions, and emotional development. Besides, the endocrine system plays an indispensible role in helping the body cope with a number of biological events such as stress and cellular mechanisms. For this, the endocrine system market works synchronously with the nervous system.

Hormones are essentially the chemical messengers of our body, working to transfer signals between various sets of cells. These signals relayed by our hormones can only be deciphered by cell sets that are genetically capable of doing so. The hormone levels in our body could fluctuate owing various internal and external changes including variations in mineral levels and body fluids. Other factors such as infections and stress could also have an adverse effect on our hormone levels.

This is where the importance of endocrine tests is seen. These tests are carried out to determine the exact hormone levels in the body, and these results help medical practitioners prescribe the right medication to restore ideal hormone levels—correcting hyposecretion (shortage) or hypersecretion (surplus) of hormones.

Early diagnosis via the right endocrine tests can help medical practitioners in the early diagnosis as well as treatment of disorders. In the recent years, endocrine tests have gained a larger scope given the consistent rise in health conditions such as obesity, infertility and diabetes. This, in turn, has also caused consumers to widely accept endocrine kits in the healthcare market.

The market report by Transparency Market Research also states that the Endocrine Tests market is poised to benefit from the fact that a number of market players have successfully introduced diagnostic platforms that are based on cutting-edge technology. This, coupled with a growing awareness regarding healthcare, and the preference of consumers to opt for operating test platforms that are rapid yet accurate has further broadened the scope of the methodologies and products used in conducting endocrine tests.

The report also further analyzes certain restraints that are hampering the growth of Endocrine Tests. These factors include reimbursement policies that are inflexible and development costs that continue to remain high. These factors are seen as potential restraints in the global market for Endocrine Testing.

The market research report also comprises various analyses centered on markets for insulin tests, thyroid tests, follicle stimulating hormone tests, as well as human chorionic Gonadotropin tests. According to the report, the highest growth rate within the Endocrine Testing market is likely to be observed in the insulin tests market over the period of the forecast. Much of this growth will come from the high number of diabetes patients diagnosed worldwide. The market for thyroid tests will also be propelled owing to the emerging link between cardiovascular disease and thyroid dysfunction.

The report also covers the diagnostic technology market that comprises tandem mass spectrometry, immunoassays, as well as sensor technologies. Furthermore, it dwells on the role expected to be played by ambulatory care centers, commercial laboratories and home-based tests on the overall endocrine testing market.

The report also offers an in-depth insight into the Endocrine Testing market from the regional perspective. It predicts that maximum growth within this market over the forecast period will be recorded in the Asia-Pacific region. The other key topics covered in this report include an analysis of key players that will influence growth and trends in the endocrine testing market.

To purchase the report on “Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” please visit
Transparency Market Research
Nitin Sirsat
90 State Street,
Suite 700,
Albany, NY - 12207
United States